More on RNXT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/14/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

RenovoRx (NQ:RNXT)
Delayed: 0.79 -0.05 (5.95%)
Prev. Close $0.84  
Open$0.82 
52 Wk High$ 
52 Wk Low$ 
Day High$0.84 
Day Low$0.77 
P/E N/A  
EPS$ 
Volume483,138 

Friends, Peers and Foes (?): CELC, ONCY, OSTX SLS (more...)

Feb 27, 2026 08:30 AM RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum
Feb 26, 2026 08:30 AM RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Radiology Annual Scientific Meeting
Feb 10, 2026 08:30 AM RenovoRx forms medical advisory board for RenovoCath device
Feb 10, 2026 08:30 AM RenovoRx Establishes RenovoCath® Medical Advisory Board
Feb 6, 2026 07:02 AM Form 8-K RenovoRx, Inc. For: Feb 06
Feb 5, 2026 08:30 AM RenovoRx names Mark Voll as chief financial officer
Feb 5, 2026 08:30 AM RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer
Feb 4, 2026 08:30 AM RenovoRx Announces Clinical Data Supporting the TAMP™ Therapy Platform will be Presented at the SIO 2026 Annual Scientific Meeting
Jan 30, 2026 12:14 PM Form SCHEDULE 13G/A RenovoRx, Inc. Filed by: HIRSCHMAN ORIN
Jan 30, 2026 01:01 AM Jones Trading Starts RenovoRx Inc. (RNXT) at Buy
View All Articles

Entities mentioned with RNXT

View All Entities